PROEHL GERALD T 4
4 · Dermata Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
PROEHL GERALD T
DirectorPresident, CEO and Chairman10% Owner
Transactions
- Award
Stock Option (right to buy)
2026-01-02+37,500→ 37,500 totalExercise: $2.18Exp: 2036-01-01→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.